There are many important considerations to
address in building your new drug program.
Without a doubt, one of the most critical is funding
to get you to your next milestone. As you grapple
with funding issues, it can be useful to consider the
point of view of a potential investor.
Why? Because investors are betting on you to manage
development effectively and to move quickly. In assembling
this guide, we asked investment veterans and biopharma
executives what questions they ask (and have been asked)
when both parties sit down together. Answer these questions
well and your potential investors are that much more likely to
support your company’s vision.
We’ve also included a few “red flags” that you should avoid.
Sometimes knowing what gives potential funders pause is just
as important as knowing what they are likely to ask
Please fill all the required * fields.